Columvi
NDC 50242-125, Glofitamab, solution, concentrate, from Genentech, Inc..
- Product NDC
- 50242-125
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761309
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLOFITAMAB2.5 mg/2.5mL
Pharmacologic classes
Bispecific CD20-directed CD3 T Cell Engager [EPC]; CD20-directed Antibody Interactions [MoA]; CD3 Receptor Agonists [MoA]; CD3-directed Antibody Interactions [MoA]; Cytochrome P450 Inhibitors [MoA]; Increased Cytokine Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-125-01 | 50242012501 | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-125-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3516e753-f064-4d30-9bd5-e3f2e143f75dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-125
Use it
Look up 50242-125 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.